NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 15 மணி நேரத்திற்கு முன்இன்று 30 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
₹236.50 கோடி R32 திறன்: சூரத்தில் Navin Fluorine வணிக உற்பத்தியைத் தொடங்கியது
Navin Fluorine, சூரத்தில் உள்ள தனது கூடுதல் ஹைட்ரோஃப்ளூரோகார்பன் (HFC) ஆலையின் வணிகச் செயல்பாடுகளைத் தொடங்கியுள்ளது. இதன் திறன் அதிகபட்சம் 15,000 MTPA R32 சமமான அளவு. அக்டோபர் 30, 2025 அன்று இயக்குநர் குழு அங்கீகரித்த இந்தத் திட்டத்திற்கு ₹236.50 கோடி மூலதனச் செலவு ஆனது (நிகர மதிப்பில் ~5.9%, TTM வருவாயில் ~6.5%). உற்பத்தி படிப்படியாக அதிகரிக்கும். அடுத்த தலைமுறை குளிரூட்டி வாயுக்களில் நிறுவனத்தின் இருப்பு விரிவடையும்.
உச்சம் நம்பிக்கை
என்ன மாறியதுNavin Fluorine தனது ₹236.50 கோடி HFC (R32) விரிவாக்கத் திட்டத்தை கட்டுமானக் கட்டத்திலிருந்து நவம்பர் 12, 2026 அன்று செயல்பாட்டு வணிக உற்பத்திக்கு மாற்றியுள்ளது.
ஏன் இது முக்கியம்வயதான HCFC வாயுக்கள் படிப்படியாக நீக்கப்படுவதால், மாற்று குளிரூட்டி வாயுக்களில் வருவாய் வளர்ச்சிக்கு அதிகபட்சம் 15,000 MTPA R32 சமமான திறன் ஆதரவளிக்கும்.
மூலதனச் செலவு: ₹236.50 கோடிசேர்க்கப்பட்ட திறன்: upto 15K MTPA R32 equivalentமூலதனச் செலவு vs நிகர மதிப்பு: ~5.9%மூலதனச் செலவு vs TTM வருவாய்: ~6.5%
📅 குறுகிய காலம்திட்டம் தாமதமின்றி அட்டவணைப்படி இயக்கத்துக்கு வந்ததால் நேர்மறை உணர்வு; பயன்பாடு உடனடியாக அதிகரிக்கத் தொடங்கும்.
📈 நீண்ட காலம்ஃப்ளோரோகெமிக்கல்ஸ் துறையில் சந்தை தலைமைத்துவத்தை வலுப்படுத்தும்; R32 மற்றும் குறைந்த-GWP குளிரூட்டிகளை நோக்கிய கட்டமைப்பு மாற்றத்துக்கு உதவும்.
⚠ அபாய எச்சரிக்கைகள்
பயன்பாடு அதிகரிப்பதில் அபாயங்கள்
ஃப்ளோர்ஸ்பார் மூலப்பொருள் விலை ஏற்ற இறக்கம்
HFC வாயுக்களுக்கான உலகளாவிய விலை மற்றும் ஒதுக்கீட்டு இயக்கவியல்
👀 கவனிக்க வேண்டியவை
அடுத்த காலாண்டு முடிவுகள் அறிவிப்புகளில் திறன் அதிகரிப்பு மைல்கற்களையும் குளிரூட்டி பிரிவுக்கான வால்யூம் பங்களிப்பையும் கவனியுங்கள்.
Navin Fluorine Q2 FY27 Call: Solstice Contract Extended by $180M, H1 PAT Tops ₹500 Cr
Navin Fluorine submitted its Q2 & H1 FY27 earnings call transcript, highlighting that H1 FY27 PAT crossed ₹500 crore with an EPS of ₹100. The company announced that its existing HFO supply contract with Solstice Advanced Materials has been extended by 4 years until December 2032, offering an additional revenue potential of approximately $180 million (~₹1,500 crore). Management declared an interim dividend of ₹8 per equity share (face value ₹2). Ongoing projects include the ₹125 crore cGMP-4 Phase 2 expansion for CDMO (operational by end of Q4 FY27) and the Chemours advanced cooling project commissioning in Q3 FY27.
உச்சம் நம்பிக்கை
என்ன மாறியதுFiling of the full earnings call transcript following Q2 FY27 results, detailing ongoing capex updates and long-term contract extensions.
ஏன் இது முக்கியம்The $180M contract extension provides medium-to-long term revenue visibility through 2032, while upcoming CDMO and cooling capacities underpin future growth.
H1 FY27 PAT: > INR500 croresSolstice contract extension value: USD180 millionInterim dividend per share: INR8cGMP-4 Phase 2 capex: INR125 கோடி
📅 குறுகிய காலம்Neutral to mildly positive as the transcript confirms steady execution across capex projects and pricing resilience in HFC/HFO.
📈 நீண்ட காலம்Solid visibility into high-value specialty and CDMO verticals with multi-year customer commitments through 2032.
⚠ அபாய எச்சரிக்கைகள்
Global pricing fluctuations and patent expiry risks in fluorochemicals
Execution delays across multi-facility ongoing capex
👀 கவனிக்க வேண்டியவை
Track the commissioning timelines of the Chemours project in Q3 FY27 and the ₹125 crore cGMP-4 Phase 2 facility in Q4 FY27.
Navin Fluorine Declares ₹8/Share Interim Dividend; Record Date November 5, 2026
Navin Fluorine International Limited has announced an interim dividend of ₹8 per equity share of face value ₹2 each for FY 2026-27. The record date to determine shareholder eligibility is November 5, 2026, and the dividend is scheduled for payout on or after November 26, 2026. The company also communicated procedural guidelines regarding Tax Deducted at Source (TDS), specifying standard deduction rates of 10% for resident shareholders and 20% (or treaty rate) for non-residents. Shareholders must submit exemption forms and tax documentation by November 5, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுNavin Fluorine declared an interim dividend of ₹8 per share and circulated tax deduction guidelines to shareholders.
ஏன் இது முக்கியம்Represents an ordinary cash distribution to shareholders, reflecting regular capital return with no material disruption to business operations.
Interim Dividend per share: ₹ 8/-Face Value per share: ₹ 2/-ரெக்கார்ட் தேதி: நவம்பர் 05, 2026Payment Date: நவம்பர் 26, 2026Resident TDS Rate: 10%
📅 குறுகிய காலம்Stock will trade ex-dividend around the record date of November 5, 2026; payout to occur on or after November 26, 2026.
📈 நீண்ட காலம்Limited; routine dividend distribution that reflects steady capital allocation.
👀 கவனிக்க வேண்டியவை
Eligible shareholders seeking lower or nil withholding tax must ensure valid PAN-Aadhaar linking and submit necessary forms (e.g., Form 121/treaty documents) to the RTA by November 5, 2026.
Navin Fluorine Q2 FY27 Sales Rise 57% YoY to ₹1,190.7 Cr; Extends HFO Deal to $590M
Navin Fluorine reported strong Q2 FY27 consolidated net revenue of ₹1,190.74 Cr, up 57% YoY and 14% QoQ, driven by broad-based growth across CDMO (+78%), Specialty (+58%), and HPP (+49%). Operating EBITDA rose 65.5% YoY to ₹407.45 Cr with margins expanding 176 bps YoY to 34.22%. Additionally, the company announced an extension of its HFO supply contract with Solstice Advanced Materials US by 4 years, adding ~$180 million and bringing the total contract value to ~$590 million over 11 years. Significant ongoing capex projects include a ₹236.5 Cr R32 expansion (15,000 MTPA) commissioning shortly, and Phase II cGMP4 (₹125 Cr) slated for Q4 FY27.
உச்சம் நம்பிக்கை
என்ன மாறியதுNavin Fluorine published its Q2 FY27 investor presentation highlighting 57% YoY revenue growth and a 4-year extension of its major HFO export contract.
ஏன் இது முக்கியம்Demonstrates robust operating leverage with EBITDA margins topping 34% alongside visible mid-term order flows in high-value CDMO and refrigerant segments.
Q2 FY27 Net Revenue: ₹1,190.74 கோடிQ2 FY27 Operating EBITDA: ₹407.45 கோடிHFO Extended Contract Value: ~$590 millionR32 Capex Amount: ₹236.5 CrsQ2 வருவாய் vs TTM வருவாய்: ~32.8%
📅 குறுகிய காலம்Market sentiment should be supported by strong margin delivery (34.2%) and execution progress across pipeline projects.
📈 நீண்ட காலம்Contract extensions in HFO and new applications in advanced materials (liquid cooling, defence) reinforce high-margin growth durability.
⚠ அபாய எச்சரிக்கைகள்
High dependence on raw material imports (fluorspar pricing volatility)
Export logistics risk with ~56-67% revenues derived from international markets in key segments
👀 கவனிக்க வேண்டியவை
Track the upcoming commissioning of the 15,000 MTPA R32 capex and commercial delivery execution for the Chemours project in Q4 FY27.
Navin Fluorine Q2 PAT Rises 81.5% YoY to ₹269.23 Cr; Declares ₹8 Interim Dividend
Navin Fluorine reported strong Q2 FY27 results, with consolidated revenue from operations surging 57.0% YoY to ₹1,190.74 crore compared to ₹758.42 crore in Q2 FY26. Consolidated profit after tax grew 81.5% YoY to ₹269.23 crore from ₹148.37 crore in the corresponding quarter last year. Alongside the results, the Board declared an interim dividend of ₹8 per equity share (400% on ₹2 face value). The record date for the dividend is set for November 05, 2026, with payment scheduled on or after November 26, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுNavin Fluorine reported an 81.5% YoY net profit growth for Q2 FY27 and announced an interim dividend of ₹8 per share.
ஏன் இது முக்கியம்Demonstrates robust operating leverage and top-line scaling in its fluorochemical business, delivering strong cash flow generation to support shareholder payouts.
Q2 Consolidated Revenue: ₹1,190.74 கோடிQ2 Consolidated PAT: ₹269.23 கோடிInterim Dividend per share: ₹ 8/-ரெக்கார்ட் தேதி: நவம்பர் 05, 2026Operating cash flow (H1): ₹456.46 கோடி
📅 குறுகிய காலம்The strong operational beat and interim dividend announcement are likely to be received positively by the market ahead of the November 5 record date.
📈 நீண்ட காலம்Sustained revenue growth above ₹1,000 crore quarterly confirms continuous demand scaling in fluorochemical and CDMO verticals, reinforcing high ROCE profile.
⚠ அபாய எச்சரிக்கைகள்
Raw material price volatility (Fluorspar) and export logistics risks
👀 கவனிக்க வேண்டியவை
Track the upcoming ex-dividend date around November 05, 2026, and monitor management commentary on capacity ramp-ups and specialty chemical margin sustainability in subsequent investor calls.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
NFASL Extends HFO Contract by 4 Years, Adds ~$180M Revenue Potential to Total $590M
Navin Fluorine International's subsidiary, Navin Fluorine Advanced Sciences Limited (NFASL), has executed a contract amendment with Solstice Advanced Materials US, Inc. (assignee from Honeywell). The contract for the manufacture and supply of Hydrofluoroolefins (HFO) at Dahej has been extended by 4 years to December 2032. This extension brings an incremental revenue potential of ~$180 million, lifting the total 11-year contract value from $410 million to ~$590 million. The incremental revenue of ~$180 million (approx. ₹1,500 cr) represents over 41% of Navin Fluorine's TTM revenue of ₹3,634 cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுNFASL's existing 7-year, $410 million supply contract with Honeywell/Solstice has been extended by 4 years with an additional ~$180 million in revenue commitment.
ஏன் இது முக்கியம்Provides multi-year revenue visibility through 2032 for the high-margin HFO vertical and reinforces NFASL's partnership with a key global innovator.
Additional contract value: ~$180 millionTotal revised contract value: ~$590 millionTenure extension: 4 years (to December 2032)Original contract value: $410 millionAdditional value vs TTM revenue: ~41%
📅 குறுகிய காலம்Positive sentiment driver as it confirms client retention and sustained demand for HFO molecules manufactured at Dahej.
📈 நீண்ட காலம்Significantly strengthens long-term earnings visibility through FY33, validating the company's multi-year investments in complex fluorine chemistry.
⚠ அபாய எச்சரிக்கைகள்
Execution and delivery timelines dependent on raw material availability and stable fluorspar prices
Client concentration risk with Solstice Advanced Materials
👀 கவனிக்க வேண்டியவை
Track capacity utilization and volume uptake at the Dahej HFO plant along with management commentary on long-term margins in upcoming quarterly earnings calls.
Navin Fluorine Commissions ₹75 Cr Dahej Multi Purpose Plant Debottlenecking
Navin Fluorine International Limited has announced the successful commissioning of its debottlenecking capacity at the Multi Purpose Plant (MPP) facility in Dahej via its wholly owned subsidiary, Navin Fluorine Advanced Sciences Limited (NFASL). The board had previously approved funding of ₹75 Crores on October 30, 2025, for this project. Commercial production and product dispatch have formally commenced as of September 29, 2026. The ₹75 Crore capex represents approximately 2.1% of TTM revenue (₹3,634 Cr) and 2.0% of net worth (₹3,666 Cr).
உச்சம் நம்பிக்கை
என்ன மாறியதுNFASL has transitioned the ₹75 Cr Dahej MPP debottlenecking project from development to operational status, starting commercial dispatches.
ஏன் இது முக்கியம்Increases high-margin specialty chemicals/CDMO manufacturing throughput and improves operating leverage with minimal incremental balance sheet stress.
Project Capex: ₹75 CroresCapex vs TTM Revenue: ~2.1%Capex vs Net Worth: ~2.0%Commercial Production Date: செப்டம்பர் 29, 2026
📅 குறுகிய காலம்Positive sentiment from project completion on schedule; dispatches start contributing immediately to Q3 FY27 volumes.
📈 நீண்ட காலம்Enhances asset sweating in complex fluorine chemistry verticals, aligning with management's CDMO and specialty chemicals growth strategy.
⚠ அபாய எச்சரிக்கைகள்
Demand slowdown or customer validation delays in key export markets
Fluorspar raw material price volatility
👀 கவனிக்க வேண்டியவை
Track capacity ramp-up and incremental revenue contribution from the Dahej MPP in the upcoming quarterly results (Q3 FY27).
CARE Ratings Upgrades Navin Fluorine Long-Term Rating to AA+ from AA
CARE Ratings has upgraded the long-term bank facility ratings of Navin Fluorine International Limited from 'CARE AA; Stable' to 'CARE AA+; Stable'. The company's wholly-owned subsidiary, Navin Fluorine Advanced Sciences Limited, also received an upgrade to 'CARE AA+ (CE)' for its credit-enhanced facilities. This upgrade reflects the company's robust financial health, evidenced by a very low Debt-to-Equity ratio of 0.03 and a 41% revenue growth in FY26. Such upgrades typically signal improved creditworthiness and can lead to lower borrowing costs for future expansions.
உச்சம் நம்பிக்கை
என்ன மாறியதுCARE Ratings has moved the company's credit rating up by one notch to AA+, indicating a higher degree of safety regarding timely servicing of financial obligations.
ஏன் இது முக்கியம்A higher credit rating reduces the risk premium demanded by lenders, potentially lowering the cost of capital. For a high-growth chemical company, this provides a competitive advantage in funding large-scale specialty chemical and CDMO projects.
Revised Parent Rating: CARE AA+Previous Parent Rating: CARE AADebt-to-Equity Ratio: 0.03Total Debt: ₹92 கோடிTTM வருவாய்: ₹3,314 கோடிசந்தை மதிப்பு: ₹42,372 கோடி
📅 குறுகிய காலம்The upgrade is likely to be viewed positively by the market as a validation of the company's financial discipline and operational scaling.
📈 நீண்ட காலம்Structurally positive; the improved rating supports the company's long-term strategy of investing in complex fluorine chemistry and high-value CDMO services.
👀 கவனிக்க வேண்டியவை
Investors should monitor the impact on interest expenses in upcoming quarterly results and watch for any new debt-funded capex announcements that leverage this improved credit profile.
Navin Fluorine Q1 FY27: PAT up 108% to ₹243 Cr; ₹215 Cr New Capex Announced
Navin Fluorine reported a strong Q1 FY27 with revenue growing 44% YoY to ₹1,044 Cr and PAT doubling to ₹243 Cr. The company announced two significant capex initiatives totaling ₹215 Cr: ₹90 Cr for advanced materials adoption and ₹125 Cr for CDMO Phase 2. A strategic partnership with DRDO for indigenous specialty materials highlights a move into high-tech defense applications. Management confirmed that the 15,000 MT R32 expansion and the Chemours project remain on track for commissioning in Q3 FY27 and Q2 FY27, respectively.
உச்சம் நம்பிக்கை
என்ன மாறியதுNavin Fluorine delivered a significant earnings beat and formally initiated ₹215 Cr in growth-oriented capex while announcing a strategic defense partnership.
ஏன் இது முக்கியம்The results validate the company's shift toward high-margin CDMO and specialty chemicals, while the new advanced materials vertical provides a long-term growth lever in sectors like defense and electronics.
📅 குறுகிய காலம்The stock is likely to react positively to the 108% PAT growth and the clear execution roadmap for upcoming capacity additions.
📈 நீண்ட காலம்Structural growth is supported by the expansion into high-value advanced materials and deepening CDMO relationships, which should sustain high margins.
⚠ அபாய எச்சரிக்கைகள்
High dependency on China for fluorspar raw material
Execution risks in scaling up lab-scale advanced materials to commercial production
👀 கவனிக்க வேண்டியவை
Monitor the timely commissioning of the R32 expansion in Q3 FY27 and the Chemours project by the end of Q2 FY27. Watch for further commercialization updates regarding the DRDO partnership and the advanced materials pipeline.
44% Revenue Growth in Q1 FY27; NAVINFLUOR Announces New Rs 125 Cr CDMO Capex
Navin Fluorine delivered a strong Q1 FY27 with revenue growing 44% YoY to Rs 1,045.1 Cr, driven by an 82% surge in the CDMO vertical. Operating EBITDA margins expanded significantly by 566 bps YoY to 34.2%, reflecting strong operating leverage. The company announced a new Rs 125 Cr Phase II capex for its cGMP4 facility to support a European CDMO major, alongside a new 'Advanced Materials' vertical targeting data centers and semiconductors. Total ongoing capex projects exceed Rs 640 Cr, representing approximately 19.5% of TTM revenue.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has moved from a period of stabilization to aggressive growth, initiating new capex in CDMO and creating a dedicated vertical for high-growth sectors like semiconductors and data centers.
ஏன் இது முக்கியம்The significant margin expansion and high-value CDMO growth indicate a structural shift toward more profitable business segments, reducing reliance on commoditized refrigerant gases.
📅 குறுகிய காலம்The stock is likely to react positively to the strong margin beat and the clear roadmap for capacity expansion across all business lines.
📈 நீண்ட காலம்The focus on complex fluorine chemistry and entry into high-growth sunrise sectors like semiconductors and liquid cooling for data centers provides a multi-year growth runway.
⚠ அபாய எச்சரிக்கைகள்
High client concentration in the CDMO segment (European major)
Execution risk across multiple simultaneous large-scale capex projects
👀 கவனிக்க வேண்டியவை
Monitor the commissioning of the R32 expansion in Q3 FY27 and the Chemours liquid cooling project in Q2 FY27 as immediate revenue catalysts. Investors should also track the ramp-up of the newly initiated CDMO and Advanced Materials projects for long-term margin sustainability.
Navin Fluorine Q1 PAT Jumps 107% to ₹243 Cr; Approves ₹90 Cr Capex for Advanced Materials
Navin Fluorine reported a robust Q1 FY27 with consolidated revenue from operations growing 44% YoY to ₹1,045.08 Cr. Net profit more than doubled to ₹243.31 Cr, up from ₹117.16 Cr in the same quarter last year, reflecting strong operating leverage. Additionally, the Board approved a ₹90 Cr capital expenditure to scale its Advanced Materials portfolio from lab to commercial qualification at the Surat unit. This capex, funded via internal accruals, represents approximately 2.45% of the company's net worth.
உச்சம் நம்பிக்கை
என்ன மாறியதுNavin Fluorine has delivered a significant earnings beat with 100%+ profit growth and initiated a new investment phase for its Advanced Materials vertical.
ஏன் இது முக்கியம்The strong results demonstrate high operating leverage and successful scaling of high-value chemical verticals, while the new capex signals a strategic move to commercialize lab-scale innovations.
Q1 FY27 Revenue: ₹1,045.08 கோடிQ1 FY27 PAT: ₹243.31 கோடிApproved Capex: ₹90 கோடிCapex vs Net Worth: ~2.45%YoY PAT Growth: 107.6%
📅 குறுகிய காலம்The stock is likely to react positively to the substantial jump in profitability and the announcement of growth-oriented capex.
📈 நீண்ட காலம்The expansion into commercial-scale Advanced Materials by FY28 could structurally enhance the company's product mix and margin profile.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in scaling lab-scale products to commercial qualification
Dependency on the Surat unit for this specific expansion
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution timeline of the ₹90 Cr Surat expansion and the company's ability to maintain these elevated operating margins in subsequent quarters.
Navin Fluorine Partners with DRDO for Indigenous Sodium Borohydride Bulk Manufacturing
Navin Fluorine has signed an agreement with India’s Defence Research and Development Organisation (DRDO) under the Technology Development Fund (TDF) scheme. The project involves the indigenous manufacturing of Sodium Borohydride in bulk, a critical material for the defence sector. DRDO will provide both technological support and grant-in-aid to facilitate this development. While the specific contract value is not disclosed, this partnership marks a strategic entry into the high-barrier defence chemicals segment, leveraging the company's existing expertise in complex chemistry.
உச்சம் நம்பிக்கை
என்ன மாறியதுNavin Fluorine has transitioned from a commercial chemical supplier to a strategic partner for the Ministry of Defence (DRDO) for critical material indigenization.
ஏன் இது முக்கியம்This partnership provides Navin Fluorine entry into the defence sector, which typically offers high margins and long-term contract stability. It also validates the company's R&D capabilities in handling complex chemical processes.
📅 குறுகிய காலம்The announcement is likely to be viewed positively by the market as it aligns with the 'Make in India' defence narrative, potentially supporting the current valuation premium.
📈 நீண்ட காலம்This could establish a new high-margin revenue vertical in defence chemicals, complementing the company's existing CDMO and Specialty Chemical businesses over the next 3-5 years.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in scaling indigenous technology to bulk manufacturing
Dependency on government/DRDO timelines for project progression
👀 கவனிக்க வேண்டியவை
Investors should monitor the timeline for the transition from process development to commercial bulk production. Future disclosures regarding the size of the grant-in-aid and potential order book from the Ministry of Defence will be key to quantifying the financial impact.
Navin Fluorine to Invest ₹5.50 Cr for 26% Stake in 5MW Hybrid Power SPV
Navin Fluorine's subsidiary, NFASL, is investing up to ₹5.50 crores to acquire a 26% stake in Pro-Zeal Green Power Twenty Private Limited, a Special Purpose Vehicle (SPV). This SPV will set up a hybrid wind and solar power plant in Gujarat to supply 5MW of captive power to NFASL's Dahej unit. The agreement includes a 15-year lock-in period for power supply and offtake, aimed at reducing operational power costs. The investment will be made via equity and compulsory convertible debentures, with completion expected within 12 months.
முக்கிய அம்சங்கள்
Investment of up to ₹5.50 crores for a 26% equity and CCD stake in a power SPV.Secures 5MW of hybrid (wind and solar) power for the Dahej manufacturing facility.Long-term power supply and offtake agreement established with a 15-year lock-in.Strategic move to achieve significant savings on power costs and enhance sustainability initiatives.The SPV is a greenfield entity incorporated in December 2025 specifically for this project.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step towards operational efficiency and ESG compliance. While the investment amount is small, the long-term reduction in power costs will support margin stability at the Dahej unit.
Navin Fluorine FY26 PAT Jumps 130% to ₹664 Cr; EBITDA Margins Expand to 32.6%
Navin Fluorine reported a stellar FY26 performance with consolidated revenue growing 41% Y-o-Y to ₹3,314 crore and PAT surging 130% to ₹664 crore. The company achieved a significant margin expansion of 992 bps, reaching an EBITDA margin of 32.6% for the full year. Growth was broad-based, led by the CDMO segment which grew 61% in Q4 and Specialty Chemicals which grew 39%. The company also outlined a robust capex pipeline of over ₹430 crore across HFC, MPP, and Advanced Materials to drive future growth.
முக்கிய அம்சங்கள்
FY26 Consolidated Revenue grew 41% Y-o-Y to ₹3,313.9 crore, with EBITDA doubling to ₹1,081.7 crore.EBITDA margins expanded significantly by 992 bps Y-o-Y to 32.6% for FY26, driven by improved realizations.CDMO business showed the strongest momentum with 61% revenue growth in Q4FY26 and a strong therapeutic pipeline.Announced ₹236.5 crore capex for R32 capacity with a peak revenue potential of ₹600-825 crore by Q3FY27.Return on Equity (ROE) improved dramatically from 11.5% in FY25 to 20.1% in FY26.
👀 கவனிக்க வேண்டியவை
Investors should view the strong margin recovery and aggressive capex plans as a positive sign of long-term growth. The stock remains a key play in the specialty chemicals and CDMO space given its improving return ratios and order visibility.
Navin Fluorine Reports Strong FY26 Results with 41% Revenue Growth and 103% EBITDA Surge
Navin Fluorine International Limited reported a stellar financial performance for FY26, with consolidated sales rising 41% YoY to Rs. 3,313.9 crores. Operating EBITDA witnessed a massive jump of 103% YoY to Rs. 1,081.7 crores, with margins expanding by 992 bps to 32.6%. Profit After Tax (PAT) also grew significantly by 130% YoY to Rs. 663.56 crores. The company has also announced an upcoming interaction schedule with institutional investors via Jefferies in Singapore and Hong Kong from June 9th to 12th, 2026.
முக்கிய அம்சங்கள்
Consolidated FY26 revenue increased by 41% YoY to Rs. 3,313.9 crores.Operating EBITDA for FY26 surged 103% YoY to Rs. 1,081.68 crores, with margins at 32.6%.Consolidated PAT for FY26 grew 130% YoY to Rs. 663.56 crores from Rs. 288.60 crores.Ongoing HFC expansion project of 15,000 MTPA R32 capacity requires Rs. 236.5 crores capex and targets peak revenue of Rs. 600-825 crores.Q4FY26 revenue grew 34% YoY to Rs. 937.71 crores, while Q4 PAT grew 124% YoY to Rs. 212.62 crores.
👀 கவனிக்க வேண்டியவை
Investors should view these strong earnings and margin expansions positively, supported by robust growth across Specialty Chemicals, CDMO, and HPP segments. The ongoing capex plans provide strong visibility for future revenue growth, making it a solid hold/buy candidate on dips.
Navin Fluorine Q4 FY26 PAT Jumps 124% YoY to ₹212.6 Cr; EBITDA Margins Expand to 34.2%
Navin Fluorine reported a stellar performance for FY26, with consolidated revenue growing 41% YoY to ₹3,313.9 crore and PAT surging 130% to ₹663.6 crore. The company witnessed significant margin expansion, with Operating EBITDA margins reaching 32.6% for the full year, up 992 bps from FY25. Growth was robust across all segments, particularly in CDMO (+61% in Q4) and Specialty Chemicals (+39% in Q4). Management is aggressively pursuing capex, including a ₹236.5 crore HFC expansion with a peak revenue potential of up to ₹825 crore per annum.
முக்கிய அம்சங்கள்
Consolidated FY26 Revenue grew 41% YoY to ₹3,313.9 Cr, while PAT surged 130% to ₹663.6 Cr.Operating EBITDA margins expanded significantly by 992 bps YoY to 32.6% for the full year FY26.The CDMO business vertical showed the strongest momentum with 61% YoY revenue growth in Q4 FY26.Return on Equity (ROE) and ROCE improved drastically to 20.1% and 21.0% respectively in FY26.Announced ₹236.5 Cr capex for HFC capacity (R32) with a peak revenue potential of ₹600-825 Cr per annum.
👀 கவனிக்க வேண்டியவை
The significant margin recovery and robust growth in high-value segments like CDMO and Specialty Chemicals indicate strong execution and pricing power. Investors should maintain a positive outlook given the doubling of ROE and the substantial revenue visibility from upcoming capex projects.
Navin Fluorine Announces ₹8.60 Final Dividend for FY26; Record Date Set for June 12, 2026
Navin Fluorine International Limited has recommended a final dividend of ₹8.60 per equity share for the financial year ended March 31, 2026. The company has fixed June 12, 2026, as the record date to determine shareholder eligibility, with the dividend payment scheduled for on or after August 13, 2026. In compliance with the Finance Act 2020, the company will deduct Tax Deducted at Source (TDS) at 10% for resident shareholders with a valid PAN and 20% for those without. Non-resident shareholders may benefit from lower tax treaty rates upon submission of required documentation by the record date.
முக்கிய அம்சங்கள்
Recommended final dividend of ₹8.60 per equity share of face value ₹2 for FY 2025-26.Record date for dividend eligibility is June 12, 2026, with payment starting August 13, 2026.Standard TDS rate of 10% for resident shareholders; 20% for those without valid PAN or Aadhaar linkage.TDS exemption for resident individuals if total dividend income in FY 2026-27 does not exceed ₹10,000.Non-resident shareholders can opt for Tax Treaty rates by submitting TRC and Form 10F by the record date.
👀 கவனிக்க வேண்டியவை
Shareholders should ensure their PAN is updated and linked with Aadhaar in their demat accounts by June 12, 2026, to avoid a higher TDS rate of 20%. Non-resident investors should submit necessary tax residency documents to the RTA to avail of lower treaty benefits.
Navin Fluorine FY26 PAT Jumps 130% to ₹664 Cr; Declares ₹8.6 Dividend
Navin Fluorine reported a robust performance for FY26, with annual revenue growing 41% to ₹3,314 crores and PAT more than doubling to ₹664 crores. The company achieved significant margin expansion, with FY26 EBITDA margins reaching 32.6%, up 992 basis points year-on-year. Key growth drivers included strong performance in Specialty Chemicals and CDMO segments, alongside the successful commissioning of the AHF plant. Management has declared a final dividend of ₹8.6 per share and maintains a near-debt-free balance sheet with a net debt-to-equity ratio of 0.01x.
முக்கிய அம்சங்கள்
Consolidated FY26 revenue grew 41% YoY to ₹3,314 crores, driven by broad-based momentum across all verticals.Operating EBITDA for the full year more than doubled to ₹1,082 crores, with margins expanding by 992 bps to 32.6%.Net working capital cycle improved significantly to 74 days from 90 days, reflecting better operational efficiency.R32 capacity expansion of 15,000 MTPA and Dahej MPP debottlenecking are both on track for Q3 FY27 commissioning.Board declared a final dividend of ₹8.6 per equity share (430% of face value).
👀 கவனிக்க வேண்டியவை
Investors should view the strong margin expansion and capacity ramp-ups as positive indicators for sustained growth. Monitor the commissioning of the R32 and Chemours projects in FY27 for further revenue visibility.
Navin Fluorine FY26 PAT Surges 130% to ₹664 Cr; EBITDA Margins Expand to 32.6%
Navin Fluorine reported a stellar performance for FY26, with consolidated revenue growing 41% YoY to ₹3,313.9 crore and PAT jumping 130% to ₹663.6 crore. The company saw massive margin expansion, with FY26 Operating EBITDA margins rising by 992 bps to 32.6%. Growth was broad-based across segments, led by CDMO (+61% in Q4) and Specialty Chemicals (+39% in Q4). The company is also executing significant capex of over ₹430 crore across HFC, MPP, and Advanced Materials to drive future growth.
முக்கிய அம்சங்கள்
FY26 Consolidated Revenue grew 41% YoY to ₹3,313.9 Cr, with Operating EBITDA doubling to ₹1,081.7 Cr.Q4FY26 CDMO segment revenue grew 61% YoY to ₹186 Cr, supported by commercial supplies from cGMP4.Operating EBITDA margins for Q4FY26 stood at 34.2%, an expansion of 875 bps compared to Q4FY25.Announced ₹236.5 Cr capex for additional HFC capacity (15,000 MTPA R32) with peak revenue potential of ₹600-825 Cr.Return on Capital Employed (ROCE) nearly doubled from 11.5% in FY25 to 21.0% in FY26.
👀 கவனிக்க வேண்டியவை
The significant margin expansion and robust growth in high-value segments like CDMO indicate a strong structural turnaround. Investors should maintain a positive outlook as upcoming capex commissioning in FY27 provides clear revenue visibility.
Navin Fluorine Recommends ₹8.60 Final Dividend; Sets June 12, 2026 as Record Date
Navin Fluorine International Limited has recommended a final dividend of ₹8.60 per equity share for the financial year 2025-2026, representing a 430% payout on the face value of ₹2. The company has fixed June 12, 2026, as the record date to determine shareholder eligibility for this payment. The dividend is subject to approval at the upcoming Annual General Meeting on August 06, 2026. If approved, the payout will be processed on or after August 13, 2026.
முக்கிய அம்சங்கள்
Final dividend of ₹8.60 per equity share recommended for FY 2025-2026Dividend payout represents 430% of the face value of ₹2 per shareRecord date for dividend eligibility fixed as Friday, June 12, 2026Payment to be made on or after August 13, 2026, post-AGM approvalAnnual General Meeting (AGM) scheduled for August 06, 2026
👀 கவனிக்க வேண்டியவை
Investors seeking to benefit from the dividend should ensure they hold the shares before the ex-dividend date, which typically precedes the June 12 record date. The payout reflects the company's commitment to returning capital to shareholders.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
